The Latin America generic drugs market has been gaining considerable momentum in recent years. Valued at USD 36.1 billion in 2023, the market is projected to grow at a compound annual growth rate (CAGR) of 6.33% between 2024 and 2032, reaching an estimated USD 62.7 billion by the end of the forecast period. This growth is fuelled by a combination of increasing government support, expanding...